Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

New Analyst Forecast: $BBIO Given $90.0 Price Target

None

We just received data on a new analyst forecast for $BBIO. Raghuram Selvaraju from HC Wainwright & Co. set a price target of 90.0 for BBIO.

To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.

$BBIO Price Targets

Multiple analysts have issued price targets for $BBIO recently. We have seen 14 analysts offer price targets for $BBIO in the last 6 months, with a median target of $67.5.

Here are some recent targets:

  • Raghuram Selvaraju from HC Wainwright & Co. set a target price of $90.0 on 10/29/2025
  • Martin Auster from Raymond James set a target price of $59.0 on 10/21/2025
  • Eliana Merle from UBS set a target price of $82.0 on 09/12/2025
  • Anupam Rama from JP Morgan set a target price of $70.0 on 09/03/2025
  • Greg Harrison from Scotiabank set a target price of $57.0 on 08/06/2025
  • Leland Gershell from Oppenheimer set a target price of $61.0 on 08/06/2025
  • Josh Schimmer from Cantor Fitzgerald set a target price of $95.0 on 07/29/2025

$BBIO Congressional Stock Trading

Members of Congress have traded $BBIO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BBIO Insider Trading Activity

BBIO Insider Trades

$BBIO insiders have traded $BBIO stock on the open market 54 times in the past 6 months. Of those trades, 0 have been purchases and 54 have been sales.

Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:

  • GENETIC DISORDER L.P. KKR sold 6,000,000 shares for an estimated $205,200,000
  • GLOBAL INVESTORS LP VIKING sold 3,500,000 shares for an estimated $154,000,000
  • NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 35 sales selling 447,312 shares for an estimated $20,290,345.
  • CHARLES J HOMCY has made 0 purchases and 3 sales selling 300,000 shares for an estimated $13,912,442.
  • FRANK MCCORMICK has made 0 purchases and 2 sales selling 174,000 shares for an estimated $8,356,344.
  • ANDREW LO sold 100,000 shares for an estimated $3,849,900
  • THOMAS TRIMARCHI (President and CFO) has made 0 purchases and 3 sales selling 59,590 shares for an estimated $2,961,803.
  • ANDREA ELLIS sold 17,167 shares for an estimated $841,183
  • HANNAH VALANTINE has made 0 purchases and 5 sales selling 8,999 shares for an estimated $379,007.
  • MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,026 shares for an estimated $84,949.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BBIO Hedge Fund Activity

We have seen 216 institutional investors add shares of $BBIO stock to their portfolio, and 141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles